The only story here that matters for AI hardware: DIAGNOS getting Health Canada approval for CARA (AI retinal imaging) is the real signal—regulatory clearance for specialized medical AI hardware finally moving beyond pilots. Everything else is noise: the papers are academic dead-ends (optimal transport? classifier-free guidance?), the "rogue agent" headline is security theater, and the SDK releases are maintenance work, not innovation. Watch medical device approvals in this space—they're where AI inference actually scales into revenue and locked-in hardware demand, unlike the chatbot arms race.